Literature DB >> 33931859

The search for anti-oxytotic/ferroptotic compounds in the plant world.

David Soriano-Castell1, Zhibin Liang1, Pamela Maher1, Antonio Currais1.   

Abstract

Oxytosis/ferroptosis is a form of non-apoptotic regulated cell death characterized by glutathione (GSH) depletion and dysregulated production of mitochondrial ROS that results in lethal lipid peroxidation. As the significance of oxytosis/ferroptosis to age-associated human diseases is now beginning to be appreciated, the development of innovative approaches to identify novel therapeutics that target the oxytosis/ferroptosis pathway could not be more timely. Due to their sessile nature, plants are exposed to a variety of stresses that trigger physiological changes similar to those found in oxytosis/ferroptosis. As such, they have evolved a rich array of chemical strategies to deal with those challenging conditions. This review details a drug discovery approach for identifying potent inhibitors of oxytosis/ferroptosis from plants for the treatment of Alzheimer's disease and related dementias, thereby highlighting the tremendous potential of plant-based research for developing new medicines while simultaneously being a catalyst for sustainability.
© 2021 The British Pharmacological Society.

Entities:  

Keywords:  dementia; drug discovery; lipid peroxidation; oxidative stress; phenotypic screening; plant secondary metabolites

Mesh:

Substances:

Year:  2021        PMID: 33931859      PMCID: PMC9291238          DOI: 10.1111/bph.15517

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   9.473


  100 in total

Review 1.  Natural Products as Sources of New Drugs from 1981 to 2014.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2016-02-07       Impact factor: 4.050

Review 2.  Medicinal plants: traditions of yesterday and drugs of tomorrow.

Authors:  Ameenah Gurib-Fakim
Journal:  Mol Aspects Med       Date:  2005-08-18

3.  Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.

Authors:  Pravat K Mandal; Sumiti Saharan; Manjari Tripathi; Geetanjali Murari
Journal:  Biol Psychiatry       Date:  2015-04-14       Impact factor: 13.382

4.  Chemical modification of the multitarget neuroprotective compound fisetin.

Authors:  Chandramouli Chiruta; David Schubert; Richard Dargusch; Pamela Maher
Journal:  J Med Chem       Date:  2011-12-20       Impact factor: 7.446

5.  Unlocking the properties of plants and fungi for sustainable development.

Authors:  Alexandre Antonelli; Rhian J Smith; Monique S J Simmonds
Journal:  Nat Plants       Date:  2019-11       Impact factor: 15.793

Review 6.  Ferroptosis and Its Potential Role in Human Diseases.

Authors:  Chu Han; Yuanyuan Liu; Rongji Dai; Nafissa Ismail; Weijun Su; Bo Li
Journal:  Front Pharmacol       Date:  2020-03-17       Impact factor: 5.810

7.  The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice.

Authors:  Marguerite Prior; Richard Dargusch; Jennifer L Ehren; Chandramouli Chiruta; David Schubert
Journal:  Alzheimers Res Ther       Date:  2013-05-14       Impact factor: 6.982

8.  A delicate balance: Iron metabolism and diseases of the brain.

Authors:  Dominic Hare; Scott Ayton; Ashley Bush; Peng Lei
Journal:  Front Aging Neurosci       Date:  2013-07-18       Impact factor: 5.750

9.  Old age-associated phenotypic screening for Alzheimer's disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa.

Authors:  Wolfgang Fischer; Antonio Currais; Zhibin Liang; Antonio Pinto; Pamela Maher
Journal:  Redox Biol       Date:  2018-12-21       Impact factor: 11.799

10.  The Value of Herbarium Collections to the Discovery of Novel Treatments for Alzheimer's Disease, a Case Made With the Genus Eriodictyon.

Authors:  Pamela Maher; Wolfgang Fischer; Zhibin Liang; David Soriano-Castell; Antonio F M Pinto; Jon Rebman; Antonio Currais
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

View more
  3 in total

1.  Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors.

Authors:  Zhibin Liang; David Soriano-Castell; Devin Kepchia; Brendan M Duggan; Antonio Currais; David Schubert; Pamela Maher
Journal:  Free Radic Biol Med       Date:  2022-01-06       Impact factor: 7.376

2.  Profiling the chemical nature of anti-oxytotic/ferroptotic compounds with phenotypic screening.

Authors:  David Soriano-Castell; Zhibin Liang; Pamela Maher; Antonio Currais
Journal:  Free Radic Biol Med       Date:  2021-11-05       Impact factor: 7.376

3.  Tilianin Reduces Apoptosis via the ERK/EGR1/BCL2L1 Pathway in Ischemia/Reperfusion-Induced Acute Kidney Injury Mice.

Authors:  Zengying Liu; Chen Guan; Chenyu Li; Ningxin Zhang; Chengyu Yang; Lingyu Xu; Bin Zhou; Long Zhao; Hong Luan; Xiaofei Man; Yan Xu
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.